Nom du produit:4-(2-(6,7-Dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)ethyl)-3H-1,2,4-triazole-3,5(4H)-dione

IUPAC Name:4-[2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalin-2-yl)ethyl]-4,5-dihydro-3H-1,2,4-triazole-3,5-dione

CAS:132788-52-4
Formule moléculaire:C15H15N5O5
Pureté:95%
Numéro de catalogue:CM221134
Poids moléculaire:345.32

Unité d'emballage Stock disponible Prix($) Quantité
CM221134-25mg in stock ǯưǯ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:132788-52-4
Formule moléculaire:C15H15N5O5
Point de fusion:-
Code SMILES:O=C(N1CCC2=NC3=C(C=C(OC)C(OC)=C3)N(C)C2=O)N=NC1=O
Densité:
Numéro de catalogue:CM221134
Poids moléculaire:345.32
Point d'ébullition:
N° Mdl:MFCD00467685
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Column Infos